SNAIL1: A master transcription factor and therapeutic target for kidney fibrosis
en-GBde-DEes-ESfr-FR

SNAIL1: A master transcription factor and therapeutic target for kidney fibrosis

08.06.2026 Compuscript Ltd

Chronic kidney disease (CKD) is a global health burden, with its progression heavily characterized by irreversible kidney fibrosis. A major driver of this fibrotic scarring is the epithelial-mesenchymal transition (EMT), a process where renal tubular epithelial cells lose their standard properties and acquire highly motile, myofibroblast-like features. While the transcription factor Snail1 (encoded by the SNAI1 gene) is widely recognized as the master switch governing EMT, the intricate molecular networks and downstream proteomic alterations it dictates during fibrosis have largely remained elusive.

This new research, published in Genes & Diseases journal by a team from Mahidol University, investigated the comprehensive proteomic landscape and multifaceted functional mechanisms driven by ectopic SNAI1 overexpression in renal tubular cells.

By establishing stably SNAI1-overexpressed renal tubular cell lines and employing advanced label-free quantitative (LFQ) proteomics, the researchers identified 233 proteins with significantly altered expression levels. Comprehensive bioinformatic enrichment and experimental validations revealed that Snail1's influence extends far beyond traditional EMT regulation. Crucially, the study demonstrated that SNAI1 overexpression triggers a profound cascade of nucleolar stress and aberrant ribosome biogenesis, evidenced by the substantial upregulation of the RNA helicase DDX1, the nucleolar protein nucleophosmin, and an expansion of nucleolar organizer regions (NORs).

Furthermore, morphological and flow cytometry analyses confirmed that these SNAI1-driven proteomic shifts force renal tubular cells into a state of cellular senescence. This senescence was robustly characterized by distinct cellular enlargement, increased internal granularity, and the elevated expression of core senescence and DNA damage markers, notably p21 and γH2AX.

Remarkably, the study also uncovered that Snail1 significantly amplifies the senescence-associated secretory phenotype (SASP), directly promoting the secretion of the matrix-degrading enzyme MMP-9, which accelerates extracellular matrix remodeling and tissue inflammation. Alongside this, the signaling cascade aggressively altered focal adhesion dynamics by upregulating the scaffolding protein paxillin, fundamentally enhancing the cell's migratory and fibrotic capacities.

Collectively, this study expands the functional landscape of SNAI1, positioning Snail1 as a central regulator of proteome-wide reprogramming, nucleolar stress, and cellular aging processes in renal cells.

By integrating proteomics with functional validation, the findings provide new mechanistic insights into kidney fibrosis and identify potential therapeutic targets within Snail1-driven pathways. Targeting these newly uncovered processes may offer innovative strategies to halt or reverse fibrotic kidney disease progression.

Reference
Title of Original Paper: Deciphering the impact of SNAI1 gene on renal tubular cell proteome, nucleolar stress, ribosome biogenesis, senescence, DNA damage response, and focal adhesion dynamics

Journal: Genes & Diseases
Genes & Diseases is a journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.

DOI: https://doi.org/10.1016/j.gendis.2025.101926

Funding Information:

The National Research Council of Thailand (NRCT)
Mahidol University (No. N42A650361)

# # # # # #

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus Cite Score: 8.4 | Impact Factor: 9.4

# # # # # #

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to Genes & Diseases may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (https://x.com/GenesNDiseases)

# # # # # #
Angehängte Dokumente
  • (A) Snail1 protein expression was evaluated in vector-control and SNAI1-overexpressed HK-2 cells by immunoblotting. (B) The Snail1 band intensity was quantified and normalized by that of GAPDH (loading control). (C) Expression and localization of Snail1 protein were also examined by immunofluorescence assay. (D) The Snail1 fluorescence intensity was evaluated in at least 100 cells across 10 random fields per sample. Each bar shows the mean ± standard error of the mean derived from three independent experiments.
  • (A) The X2K Appyter (Expression2Kinases) was utilized to predict the top 10 transcription factors relevant to SNAI1 overexpression. The stacked bar plot represents the average rank of each transcription factor across different libraries (displayed as segments in different colors). (B) The network depicting interactions among these top 10 transcription factors together with Snail1 was visualized using the STRING database.
  • (A) Paxillin expression was evaluated in vector-control and SNAI1-overexpressed HK-2 cells by immunoblotting. (B) The paxillin band intensity was quantified and normalized by that of β-actin (loading control). (C) Expression and localization of paxillin were also examined by immunofluorescence assay. (D) The paxillin fluorescence intensity was evaluated in at least 100 cells across 10 random fields per sample. Each bar shows the mean ± standard error of the mean derived from three independent experiments.
08.06.2026 Compuscript Ltd
Regions: Europe, Ireland, Asia, Thailand
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement